MDT logo

Medtronic (MDT) Cash and cash equivalents

annual cash & cash equivalents:

$2.22B+$934.00M(+72.74%)
April 1, 2025

Summary

  • As of today (May 29, 2025), MDT annual cash & cash equivalents is $2.22 billion, with the most recent change of +$934.00 million (+72.74%) on April 1, 2025.
  • During the last 3 years, MDT annual cash & cash equivalents has fallen by -$1.50 billion (-40.28%).
  • MDT annual cash & cash equivalents is now -55.35% below its all-time high of $4.97 billion, reached on April 28, 2017.

Performance

MDT Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDTbalance sheet metrics

quarterly cash & cash equivalents:

$2.22B+$978.00M(+78.87%)
April 1, 2025

Summary

  • As of today (May 29, 2025), MDT quarterly cash & cash equivalents is $2.22 billion, with the most recent change of +$978.00 million (+78.87%) on April 1, 2025.
  • Over the past year, MDT quarterly cash & cash equivalents has increased by +$934.00 million (+72.74%).
  • MDT quarterly cash & cash equivalents is now -87.13% below its all-time high of $17.23 billion, reached on January 31, 2015.

Performance

MDT quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDTbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

MDT Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+72.7%+72.7%
3 y3 years-40.3%-40.3%
5 y5 years-46.4%-46.4%

MDT Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-40.3%+72.7%-54.1%+78.9%
5 y5-year-46.4%+72.7%-65.9%+78.9%
alltimeall time-55.4%+6027.1%-87.1%+8916.3%

MDT Cash and cash equivalents History

DateAnnualQuarterly
Apr 2025
$2.22B(+72.7%)
$2.22B(+78.9%)
Jan 2025
-
$1.24B(-11.0%)
Oct 2024
-
$1.39B(+6.3%)
Jul 2024
-
$1.31B(+2.1%)
Apr 2024
$1.28B(-16.8%)
$1.28B(-20.9%)
Jan 2024
-
$1.62B(+23.8%)
Oct 2023
-
$1.31B(-2.1%)
Jul 2023
-
$1.34B(-13.2%)
Apr 2023
-
$1.54B(-65.9%)
Apr 2023
$1.54B(-58.5%)
-
Jan 2023
-
$4.52B(-6.4%)
Oct 2022
-
$4.83B(+125.6%)
Jul 2022
-
$2.14B(-42.4%)
Apr 2022
$3.71B(+3.4%)
$3.71B(+6.8%)
Jan 2022
-
$3.48B(+20.0%)
Oct 2021
-
$2.90B(-3.5%)
Jul 2021
-
$3.00B(-16.4%)
Apr 2021
$3.59B(-13.2%)
$3.59B(-29.2%)
Jan 2021
-
$5.08B(-20.9%)
Oct 2020
-
$6.42B(-1.2%)
Jul 2020
-
$6.50B(+57.0%)
Apr 2020
$4.14B(-5.8%)
$4.14B(+11.6%)
Jan 2020
-
$3.71B(-6.4%)
Oct 2019
-
$3.96B(-22.0%)
Jul 2019
-
$5.08B(+15.6%)
Apr 2019
$4.39B(+19.7%)
$4.39B(+18.6%)
Jan 2019
-
$3.70B(-5.3%)
Oct 2018
-
$3.91B(-10.7%)
Jul 2018
-
$4.38B(+19.4%)
Apr 2018
$3.67B(-26.1%)
$3.67B(-42.3%)
Jan 2018
-
$6.36B(+15.0%)
Oct 2017
-
$5.53B(+17.9%)
Jul 2017
-
$4.69B(-5.6%)
Apr 2017
$4.97B(+72.7%)
$4.97B(+79.4%)
Jan 2017
-
$2.77B(-6.3%)
Oct 2016
-
$2.95B(-3.5%)
Jul 2016
-
$3.06B(+6.4%)
Apr 2016
$2.88B(-40.6%)
$2.88B(+5.7%)
Jan 2016
-
$2.72B(+14.4%)
Oct 2015
-
$2.38B(-20.2%)
Jul 2015
-
$2.98B(-38.5%)
Apr 2015
$4.84B(+245.2%)
$4.84B(-71.9%)
Jan 2015
-
$17.23B(+1238.9%)
Oct 2014
-
$1.29B(-3.7%)
Jul 2014
-
$1.34B(-4.8%)
Apr 2014
$1.40B(+52.7%)
$1.40B(+7.6%)
Jan 2014
-
$1.30B(+22.3%)
Oct 2013
-
$1.07B(+28.7%)
Jul 2013
-
$828.00M(-9.9%)
Apr 2013
$919.00M(-21.6%)
$919.00M(-29.2%)
Jan 2013
-
$1.30B(-26.2%)
Oct 2012
-
$1.76B(+104.3%)
Jul 2012
-
$861.00M(-26.5%)
Apr 2012
$1.17B(-15.2%)
$1.17B(-1.5%)
Jan 2012
-
$1.19B(+13.5%)
Oct 2011
-
$1.05B(-24.8%)
Jul 2011
-
$1.39B(+0.8%)
Apr 2011
$1.38B(-1.3%)
$1.38B(+7.7%)
Jan 2011
-
$1.28B(+2.1%)
Oct 2010
-
$1.26B(-7.9%)
Jul 2010
-
$1.36B(-2.6%)
Apr 2010
$1.40B(+10.1%)
$1.40B(-4.3%)
Jan 2010
-
$1.46B(+77.1%)
Oct 2009
-
$826.00M(-19.2%)
Jul 2009
-
$1.02B(-19.6%)
Apr 2009
$1.27B(+19.9%)
$1.27B(-0.9%)
Jan 2009
-
$1.28B(+137.2%)
Oct 2008
-
$541.00M(-53.8%)
Jul 2008
-
$1.17B(+10.4%)
Apr 2008
$1.06B(-15.6%)
$1.06B(+45.4%)
Jan 2008
-
$729.00M(-84.4%)
Oct 2007
-
$4.68B(+436.4%)
Jul 2007
-
$873.00M(-30.5%)
Apr 2007
$1.26B
$1.26B(-39.8%)
Jan 2007
-
$2.09B(+91.5%)
DateAnnualQuarterly
Oct 2006
-
$1.09B(-21.9%)
Jul 2006
-
$1.40B(-53.4%)
Apr 2006
$2.99B(+34.1%)
$2.99B(+118.9%)
Jan 2006
-
$1.37B(-29.8%)
Oct 2005
-
$1.95B(+22.5%)
Jul 2005
-
$1.59B(-28.8%)
Apr 2005
$2.23B(+40.1%)
$2.23B(+2.1%)
Jan 2005
-
$2.19B(-4.9%)
Oct 2004
-
$2.30B(+6.8%)
Jul 2004
-
$2.15B(+35.0%)
Apr 2004
$1.59B(+8.4%)
$1.59B(+25.7%)
Jan 2004
-
$1.27B(+30.5%)
Oct 2003
-
$971.00M(-17.2%)
Jul 2003
-
$1.17B(-20.2%)
Apr 2003
$1.47B(+257.9%)
$1.47B(+0.1%)
Jan 2003
-
$1.47B(+48.2%)
Oct 2002
-
$990.90M(+13.6%)
Jul 2002
-
$872.10M(+112.3%)
Apr 2002
$410.70M(-60.1%)
$410.70M(-10.5%)
Jan 2002
-
$458.80M(+62.1%)
Oct 2001
-
$283.10M(-75.8%)
Jul 2001
-
$1.17B(+13.6%)
Apr 2001
$1.03B(+120.2%)
$1.03B(+129.6%)
Jan 2001
-
$448.80M(-23.6%)
Oct 2000
-
$587.50M(+2.1%)
Jul 2000
-
$575.20M(+23.0%)
Apr 2000
$467.80M(+104.7%)
$467.80M(+202.2%)
Jan 2000
-
$154.80M(-1.9%)
Oct 1999
-
$157.80M(-31.4%)
Jul 1999
-
$230.00M(+0.7%)
Apr 1999
$228.50M(-56.0%)
$228.50M(-34.1%)
Jan 1999
-
$346.60M(-39.4%)
Oct 1998
-
$572.30M(+120.8%)
Jul 1998
-
$259.20M(-50.1%)
Apr 1998
$519.50M(+163.2%)
$519.50M(+67.3%)
Jan 1998
-
$310.60M(+4.3%)
Oct 1997
-
$297.90M(+6.3%)
Jul 1997
-
$280.20M(+41.9%)
Apr 1997
$197.40M(+79.0%)
$197.40M(+223.1%)
Jan 1997
-
$61.10M(-31.3%)
Oct 1996
-
$89.00M(-26.5%)
Jul 1996
-
$121.10M(+9.8%)
Apr 1996
$110.30M(+12.2%)
$110.30M(-8.2%)
Jan 1996
-
$120.10M(-3.4%)
Oct 1995
-
$124.30M(-12.2%)
Jul 1995
-
$141.60M(+44.0%)
Apr 1995
$98.30M(-9.6%)
$98.30M(-24.0%)
Jan 1995
-
$129.30M(+12.4%)
Oct 1994
-
$115.00M(+49.4%)
Jul 1994
-
$77.00M(-29.2%)
Apr 1994
$108.70M(+41.2%)
$108.70M(-8.7%)
Jan 1994
-
$119.00M(+104.8%)
Oct 1993
-
$58.10M(-14.3%)
Jul 1993
-
$67.80M(-11.9%)
Apr 1993
$77.00M(-23.6%)
$77.00M(-46.3%)
Jan 1993
-
$143.50M(+6.1%)
Oct 1992
-
$135.20M(+102.4%)
Jul 1992
-
$66.80M(-33.7%)
Apr 1992
$100.80M(+13.5%)
$100.80M(+18.4%)
Jan 1992
-
$85.10M(+28.7%)
Oct 1991
-
$66.10M(-0.8%)
Jul 1991
-
$66.60M(-25.0%)
Apr 1991
$88.80M(+145.3%)
$88.80M(+24.5%)
Jan 1991
-
$71.30M(+23.6%)
Oct 1990
-
$57.70M(+3.2%)
Jul 1990
-
$55.90M(+54.4%)
Apr 1990
$36.20M(-29.4%)
$36.20M(+47.2%)
Jan 1990
-
$24.60M(-15.8%)
Oct 1989
-
$29.20M(-43.1%)
Apr 1989
$51.30M(-34.6%)
$51.30M(-34.6%)
Apr 1988
$78.50M(-31.0%)
$78.50M(-31.0%)
Apr 1987
$113.70M(-16.0%)
$113.70M(-16.0%)
Apr 1986
$135.40M(-1.2%)
$135.40M(-1.2%)
Apr 1985
$137.10M(+17.7%)
$137.10M(+17.7%)
Apr 1984
$116.50M
$116.50M

FAQ

  • What is Medtronic annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Medtronic?
  • What is Medtronic annual cash & cash equivalents year-on-year change?
  • What is Medtronic quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Medtronic?
  • What is Medtronic quarterly cash & cash equivalents year-on-year change?

What is Medtronic annual cash & cash equivalents?

The current annual cash & cash equivalents of MDT is $2.22B

What is the all time high annual cash & cash equivalents for Medtronic?

Medtronic all-time high annual cash & cash equivalents is $4.97B

What is Medtronic annual cash & cash equivalents year-on-year change?

Over the past year, MDT annual cash & cash equivalents has changed by +$934.00M (+72.74%)

What is Medtronic quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of MDT is $2.22B

What is the all time high quarterly cash & cash equivalents for Medtronic?

Medtronic all-time high quarterly cash & cash equivalents is $17.23B

What is Medtronic quarterly cash & cash equivalents year-on-year change?

Over the past year, MDT quarterly cash & cash equivalents has changed by +$934.00M (+72.74%)
On this page